Skip to main content

Abbott launches Navitor to Treat Aortic Stenosisin India

Global healthcare company, Abbott today announcedthat it has launchedits latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, makingthe minimally invasive device availablefor people in India withsevereaortic stenosis who are at high or extreme surgical risk.With the Navitorvalve, the company is advancing TAVI (also referred to as TAVR, or transcatheter aortic valve replacement) therapies with innovations including a unique design to prevent blood leaking around the valve.TheNavitorTAVI system is the latest addition to the company'scomprehensivestructural heart transcatheter portfolio thatoffers physicians and patients less invasive optionsto treatheart diseases.

 Dr Ravinder Singh Rao, Interventional and Structural Cardiologist, Lilavati Hospital, Mumbai and Chairman RHL Heart Centre & Head Complex Angioplasty – TAVI Program aid, “TAVI or transcatheter aortic valve implantation is a viable option for patients with severe, symptomatic aortic stenosis, especially those who have high surgical risk. After a transcatheter procedure, a vast majority of our patients are able to go home in a couple of days. What is especially good for physicians is the flexible catheter enabling excellent deliverability even in patients with complex anatomies.”



 Aortic stenosis is one of the most common and life-threatening heart valve diseases. It restricts blood flow through the aortic heart valve to the rest of the body, which can lead to heart failure and, in certain cases, sudden cardiac death.[i]While many people don’t have noticeable symptoms, in India, one in 40 people aged 75 and older have severe, symptomatic aortic stenosis.[ii]For these people, open-heart surgery is considered a high-risk procedure due to the potential complications stemming from age, frailty or having multiple other diseases or conditions.[iii] TAVI serves as a less invasive alternative to surgical aortic valve replacement and can reduce symptoms and improve the lives of patients with this debilitating condition.

 Prior to TAVI, the standard of care for severe aortic stenosis was surgical aortic valve replacement, but not all patients were candidates for open-heart surgery.

 More About Navitor

 Navitor features a unique fabric cuff (NaviSeal™)thatworks with the cardiac cycle to reduce or eliminate a backflow of blood around the valve frame known as paravalvular leak (PVL), a common complication following TAVI procedures. The new device is the only self-expanding TAVI system with intra-annular (within the native valve) leafletsand large frame cells–features designed to help improve access to critical coronary arteries to facilitate future interventions to treat coronary artery disease (CAD). The new design additionallyprovidesimproved hemodynamics, or better blood flow.

 The Navitordevice is implanted with Abbott's FlexNavdelivery system, whichoffers a slim design with the lowest TAVI delivery system profile, allowingtreatment of peoplewith vessels as small as 5.0 mm. The slim catheter can accommodate different aorticanatomies for stable, predictable and accurate valve delivery and placement.


 

Comments

Post a Comment

Popular posts from this blog

Smallcase Platform: 2025 Wealth Creation Strategies to Achieve Your Investment Goals

  By Dr. Vikas Gupta, CEO and Chief Investment Strategist, OmniScience Capital In the intricate world of finance, wealth creation is a universal aspiration among investors, though few truly attain it. With a plethora of investment products, philosophies, and strategies available, the challenge is identifying an approach that not only offers returns but also minimizes risk. At OmniScience Capital, we believe the key to successful wealth creation lies in a scientific and disciplined investment strategy. Our unique offerings, rooted in the principles of Scientific Investing, are designed to help you achieve your financial goals with confidence. Pioneering Global Investing and Outperforming on Smallcase Platform OmniScience Capital, a global investment management firm specializing in global and Indian equities, is a pioneer in global investing and growth vectors such as Defense and Digital Transformation. Our strategies have consistently identified and capitalized on growth vectors tha...
Post a Comment
Read more

India’s Economic Slowdown: Navigating Challenges with Resilience and how planetary alignments are suggesting an optimistic economic outlook

 By Aryan Prem Rana, Founder, VRIGHT PATH GROUP (www.vrightpath.com ) India, the world’s fastest-growing major economy, faces a challenging phase as GDP growth slows. The latest figures show Q2 growth dipping to 5.4%, the lowest in seven quarters. This decline comes as 63 of the Nifty 100 companies miss revenue estimates, raising concerns about underlying economic health. Growth Engines Sputtering The economic slowdown is most pronounced in key sectors: • Manufacturing growth has dropped to 2.2%, a sharp decline from last year’s 14.3%. • Urban consumption, a cornerstone of economic growth, is weakening. Industry stalwarts such as Reliance, HUL, and Maruti have seen market corrections of 15-23%. RBI’s Balanced Approach The Reserve Bank of India (RBI) has responded with measured policies, holding the repo rate steady at 6.5% for the eleventh consecutive meeting. This neutral policy stance balances inflation control with growth needs. In a key liquidity-boosting move, the RBI redu...
Post a Comment
Read more

Press Release: Prachay Capital Limited (Company/ Issuer / Prachay Capital) Announces Public Issue of Secured NCDs

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has announced the public issue of its Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) to raise up to ₹100 Crore. The BBB-/Stable CRISIL-rated NCDs offer investors a 13% p.a. return with monthly interest payments, making it a fixed-income investment opportunity. The proceeds from this issue of NCDs will be primarily used for the stated fund utilization. Speaking about the issue, Mr Girish Murlidhar Lakhotiya, Managing Director, Prachay Capital Limited said: "This NCD issue is a key step in Prachay Capital’s expansion strategy. With our focus on structured corporate lending and investment in private debt instruments, we aim to generate strong and sustainable returns for our investors while maintaining a robust financial profile. Prachay Capital has zero delays in servicing liabilities and has Gross NPA of 0% on its Assets Under Management (AUM). The Compa...
Post a Comment
Read more